|
FAM3D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.423500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.325150E-01 |
| Normal-vs-Stage2 |
2.399200E-01 |
| Normal-vs-Stage3 |
7.123500E-02 |
| Normal-vs-Stage4 |
3.224300E-02 |
| Stage1-vs-Stage2 |
9.223800E-01 |
| Stage1-vs-Stage3 |
1.033950E-01 |
| Stage1-vs-Stage4 |
1.646790E-04 |
| Stage2-vs-Stage3 |
6.019800E-01 |
| Stage2-vs-Stage4 |
3.211800E-01 |
| Stage3-vs-Stage4 |
7.111500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.905800E-02 |
| Normal-vs-AfricanAmerican |
2.621700E-02 |
| Normal-vs-Asian |
5.247400E-01 |
| Caucasian-vs-AfricanAmerican |
6.828600E-04 |
| Caucasian-vs-Asian |
3.398800E-01 |
| AfricanAmerican-vs-Asian |
2.939000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.007170E-01 |
| Normal-vs-Female |
8.647500E-02 |
| Male-vs-Female |
7.236600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.508410E-01 |
| Normal-vs-Age(41-60Yrs) |
1.316020E-01 |
| Normal-vs-Age(61-80Yrs) |
6.360300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.238000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.701600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.679800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.917400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.399560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.105800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.728800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.342390E-01 |
| Normal-vs-Grade 2 |
1.562990E-01 |
| Normal-vs-Grade 3 |
9.320400E-02 |
| Normal-vs-Grade 4 |
2.230400E-02 |
| Grade 1-vs-Grade 2 |
7.294000E-01 |
| Grade 1-vs-Grade 3 |
8.491800E-01 |
| Grade 1-vs-Grade 4 |
8.017800E-02 |
| Grade 2-vs-Grade 3 |
3.203200E-01 |
| Grade 2-vs-Grade 4 |
1.182270E-04 |
| Grade 3-vs-Grade 4 |
3.99810000000222E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.444840E-01 |
| Normal-vs-ccB subtype |
1.254440E-01 |
| ccA subtype-vs-ccB subtype |
7.029200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.137800E-02 |
| Normal-vs-N1 |
1.214790E-01 |
| N0-vs-N1 |
9.301400E-01 |
|
|
